Published

Antipsychotics Compared; Psychiatrist’s Research Misconduct; Teen Suicide Predictor

Summary by MedPage Today
Not all antipsychotics for schizophrenia spectrum disorder were equally effective for relapse prevention in a large comparative effectiveness study, with quetiapine performing the worst. (JAMA Network Open) In a small study of patients with bipolar depression, 39% achieved clinical response following 4 weeks of intravenous ketamine or intranasal esketamine (Spravato) while 13% achieved remission. (Journal […]
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.